| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $186K | — |
| Cost of Revenue | $7.2M | +3.8% |
| Gross Profit | $15.2M | -21.7% |
| R&D Expense | $2.4M | -20.6% |
| SG&A Expense | $12.4M | -14.1% |
| Operating Income | $437K | -78.1% |
| Pre-tax Income | $147K | -93.5% |
| Income Tax | -$111K | -112.5% |
| Net Income | $258K |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $18.6M | +3.1% |
| Accounts Receivable | $5.5M | -31.3% |
| Inventory | $13.1M | -10.4% |
| Current Assets | $41.0M | -7.8% |
| Total Assets | $65.1M | -0.5% |
| Current Liabilities | $10.2M | +6.0% |
| Long-term Debt | $7.5M | -3.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $4.6M | +264.9% |
| Capital Expenditures | $1.5M | -17.9% |
| Investing Cash Flow | -$3.8M | -104.9% |
| Financing Cash Flow | -$253K | -14.8% |
| Free Cash Flow | $3.1M | +622.3% |
| -81.0% |
| EPS (Basic) | $0.02 | -83.3% |
| EPS (Diluted) | $0.02 | -83.3% |
| Total Liabilities |
| $19.5M |
| -1.1% |
| Stockholders' Equity | $45.6M | -0.2% |